NMDA型グルタミン酸受容体
□記事を途中から表示しています
[最初から表示]
^ a b c Tikka TM (2001-6-15). ⇒“Minocycline provides neuroprotection against N-methyl-D-aspartate neurotoxicity by inhibiting microglia.”. en:Journal of Immunology. 166 (12): 7527-33. doi:10.4049/jimmunol.166.12.7527. PMID 11390507. ⇒http://www.jimmunol.org/content/166/12/7527.full.
^ a b Zhuang SY (2005-1). ⇒“Cannabinoids produce neuroprotection by reducing intracellular calcium release from ryanodine-sensitive stores.”. en:Neuropharmacology. 48 (8): 1086-96. doi:10.1016/j.neuropharm.2005.01.005. PMID 15910885. ⇒http://www.sciencedirect.com/science/article/pii/S0028390805000316.
^ a b c Fujita Y (2008-2-15). ⇒“Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the antibiotic drug minocycline.”. en:Progress in Neuro-Psychopharmacology & Biological Psychiatry. 32 (2): 336-9. doi:10.1016/j.pnpbp.2007.08.031. PMID 17884273. ⇒http://www.sciencedirect.com/science/article/pii/S0278584607003193.
^ a b c d Segnitz N (2011-9). “Effects of chronic oral treatment with aripiprazole on the expression of NMDA receptor subunits and binding sites in rat brain.”. en:Psychopharmacology. 217 (1): 127-42. doi:10.1007/s00213-011-2262-z. PMID 21484241. https://link.springer.com/article/10.1007/s00213-011-2262-z.
^ a b ⇒(+)-MK 801 (Maleate) 詳細情報 ナミキ商事株式会社
^ a b c Seeman P (2005-9). ⇒“Dopamine receptor contribution to the action of PCP, LSD and ketamine psychotomimetics.”. en:Molecular Psychiatry. 10 (9): 877-83. doi:10.1038/sj.mp.4001682. PMID 15852061. ⇒http://www.nature.com/mp/journal/v10/n9/full/4001682a.html.
^ a b c d e f “メマンチン塩酸塩 国際共通化資料（CTD）神経細胞保護作用” (pdf). 第一三共株式会社. 2016年8月3日閲覧。
^ a b c d Orser BA (1997-4). ⇒“Multiple mechanisms of ketamine blockade of N-methyl-D-aspartate receptors.”. en:Anesthesiology. 86 (4): 903-17. doi:10.1097/00000542-199704000-00021. PMID 9105235. ⇒http://anesthesiology.pubs.asahq.org/article.aspx?articleid=1948382.
^ a b c d Hirota K (1996-10). ⇒“Ketamine: Its mechanism(s) of action and unusual clinical uses.”. en:British Journal of Anaesthesia. 77 (4): 441-4. doi:10.1093/bja/77.4.441. PMID 8942324. ⇒http://bja.oxfordjournals.org/content/77/4/441.long.
^ a b c D-AP5 Item № 14539 CAS № 79055-68-8 w:Cayman Chemical
^ a b Ilyin VI (1996). ⇒“Subtype-selective inhibition of N-methyl-D-aspartate receptors by haloperidol.”. en:Molecular Pharmacology. 50 (6): 1541-50. PMID 8967976. ⇒http://molpharm.aspetjournals.org/cgi/pmidlookup?view=long&pmid=8967976.
^ a b c Ludolph AG (2010-5). “Atomoxetine acts as an NMDA receptor blocker in clinically relevant concentrations.”. en:British Journal of Pharmacology. 160 (2): 283-91. doi:10.1111/j.1476-5381.2010.00707.x. PMC 2874851. PMID 20423340. https://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2010.00707.x/abstract.
^ a b c d e f Hama R, Bennett CL. (2016-6-30). ⇒“The mechanisms of sudden-onset type adverse reactions to oseltamivir.”. en:Acta Neurologica Scandinavica.. doi:10.1111/ane.12629. PMID 27364959. ⇒http://onlinelibrary.wiley.com/doi/10.1111/ane.12629/abstract.
^ a b c d e f Hama R. (2016-9). ⇒“The mechanisms of delayed onset type adverse reactions to oseltamivir.”. Journal of Infectious Diseases. 48 (9): 651-60. doi:10.1080/23744235.2016.1189592. PMID 27251370. ⇒http://onlinelibrary.wiley.com/doi/10.1111/ane.12629/abstract.
次ページ記事の検索おまかせリスト▼オプションを表示暇つぶしWikipedia
Size:46 KB
出典: フリー百科事典『ウィキペディア（Wikipedia）』
担当:undef